Tagtociclib hydrate

PF-07104091 hydrate is a potent and selective CDK2/cyclin E1 and GSK3β inhibitor, with Kis of 1.16 and 537.81 nM, respectively. PF-07104091 hydrate has anti-tumor activity for cyclin E1-amplified cancers. (patent WO2020157652A2).


Cat. No.: EX-A5350A	Purity: >98%

	Chemical structure of Tagtociclib hydrate

For research only, Do not use for Human!

Size	Unit Price (US$)	Stock
25mg	600	in-stock
50mg	1000	in-stock
100mg	1450	in-stock
250mg	get quote	in-stock
500mg	get quote	in-stock
1g	get quote	in-stock

Send PO to E-mail:[email protected]; or Fax:+86 020 81619670

Discount Request


Synonyms	PF-07104091 hydrate
CAS No.	2733575-91-0
Purity	>98%
Formula	C19H30N6O5
Mol Weight	422.4787
Color	White to off-white
State	solid powder
Solubility	DMSO : ? 100 mg/mL
Shelf Life	>2 years if stored properly
Storage	4°C, sealed storage, away from moisture and light
Shipping	Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Reference:	[1].Douglas Carl BEHENNA, et al. Cdk2 inhibitors. WO2020157652A2.
CoA	CoA of Tagtociclib hydrate

Smiles:	O=C(C1=CC(COC)=NN1C)NC2=NNC([C@](CC3)([H])C[C@@H]3OC(NC(C)C)=O)=C2.[H]O[H]


		Search